V-Akt Murine Thymoma Viral Oncogene Homolog 2 (AKT2) Peptide
-
- Target See all AKT2 products
- AKT2 (V-Akt Murine Thymoma Viral Oncogene Homolog 2 (AKT2))
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Immunogen (Imm)
- Sequence
- RYDSLGLLEL DQRT
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Reconstitute pellet in distilled water where required. For Blocking studies, reconstitute pellet in 200µl distilled water to obtain a 0.5mg/ml peptide solution.
- Buffer
- 100µg of Lyophilised peptide, formulation De-ionized (DI) water.
- Storage
- -20 °C
- Storage Comment
- Shipped at ambient temperature, store at -20°C.
-
- Target
- AKT2 (V-Akt Murine Thymoma Viral Oncogene Homolog 2 (AKT2))
- Synonyms
- AKT2 Peptide, pkbb Peptide, pkbbeta Peptide, pkbss Peptide, prkbb Peptide, rac-beta Peptide, v-akt2 Peptide, 2410016A19Rik Peptide, AW554154 Peptide, PKB Peptide, PKBbeta Peptide, HIHGHH Peptide, PKBB Peptide, PKBBETA Peptide, PRKBB Peptide, RAC-BETA Peptide, cb945 Peptide, akt2-a Peptide, AKT serine/threonine kinase 2 Peptide, v-akt murine thymoma viral oncogene homolog 2 Peptide, thymoma viral proto-oncogene 2 Peptide, v-akt murine thymoma viral oncogene homolog 2 L homeolog Peptide, AKT2 Peptide, akt2 Peptide, Akt2 Peptide, akt2.L Peptide
-